News Merck KGaA

Equities

MRK

DE0006599905

Real-time Estimate Tradegate Other stock markets 11:23:00 2024-04-25 am EDT			5-day change	1st Jan Change
149.9 ^EUR	-1.62%		+2.18%	+4.06%

02:21pm	Scholz pledges further support for the pharmaceutical industry	DP
12:11pm	Scholz promises support for pharma sector in Germany as Merck invests	RE

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Scholz pledges further support for the pharmaceutical industry	08:21am	DP
Scholz promises support for pharma sector in Germany as Merck invests	06:11am	RE
Merck KGaA Starts Building EUR300 Million Life Science Research Center in Germany	05:18am	MT
Scholz visits Merck and Family Business Days	11:52pm	DP
US competitor Danaher boosts Merck KGaA and Sartorius	Apr. 23	DP
MERCK KGAA : Barclays reiterates its Buy rating	Apr. 19	ZD
Study: US companies outpace Europe and Asia in research spending	Apr. 18	DP
Agronomics Portfolio Company Mosa Meat Raises EUR40 Million to Beef Up Production	Apr. 17	MT
Merck KGaA Rolls Out New Genetic Stability Assay Platform	Apr. 16	MT
MERCK : A peer group tidy up	Apr. 13
Merck Announces Change of Managing Director of Merck Life Science in India	Apr. 09	CI
Caris Life Sciences Announces Partnership with Merck KGaA, Darmstadt, Germany to Discover Novel Cancer Targets and Accelerate First-In-Class Antibody Drug Conjugate Development	Apr. 05	AQ
Merck's Corporate Venture M Ventures Arm Backs Nucleai to Advance Its First-in-class Spatial AI Biomarker in Active Clinical Enrollment	Apr. 04	AQ
Caris Life Sciences Announces Partnership with Merck KGaA to Discover Novel Cancer Targets and Accelerate First-In-Class Antibody Drug Conjugate Development	Apr. 04	CI
Daiichi Sankyo and Merck Announce That the First Patient Has Been Dosed in the Rejoice-Ovarian01 Phase 2/3 Trial Evaluating the Efficacy and Safety of Investigational Raludotatug Deruxtecan (R-DXd) in Patients with Platinum-Resistant Ovarian Cancer	Apr. 03	CI
Merck : Prospectus - C-029771	Mar. 28	PU
DD: Merck KGaA: Dr. Matthias Heinzel, buy	Mar. 27	EQ
DD: Merck KGaA: Peter Guenter, buy	Mar. 27	EQ
UBS Raises Merck KGaA PT, Keeps Buy Rating	Mar. 26	MT
MERCK KGAA : Jefferies keeps its Buy rating	Mar. 26	ZD

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

MERCK : A peer group tidy up

April 13, 2024 at 04:06 pm EDT

Merck KGaA : A European big pharma with positive momentum

January 20, 2023 at 05:51 am EST